# Post-operative or Early Salvage XRT and ADT for High Risk PCa

> **NCT00949962** · PHASE3 · TERMINATED · sponsor: **European Organisation for Research and Treatment of Cancer - EORTC** · enrollment: 87 (actual)

## Conditions studied

- Prostate Cancer

## Interventions

- **DRUG:** antiandrogen therapy
- **DRUG:** leuprolide acetate
- **RADIATION:** 3-dimensional conformal radiation therapy

## Key facts

- **NCT ID:** NCT00949962
- **Lead sponsor:** European Organisation for Research and Treatment of Cancer - EORTC
- **Sponsor class:** NETWORK
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2009-10
- **Primary completion:** 2015-12
- **Final completion:** 2016-06
- **Target enrollment:** 87 (ACTUAL)
- **Why stopped:** Poorly recruiting
- **Last updated:** 2014-07-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00949962

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00949962, "Post-operative or Early Salvage XRT and ADT for High Risk PCa". Retrieved via AI Analytics 2026-07-10 from https://api.ai-analytics.org/clinical/NCT00949962. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*